APOE contributes to longitudinal impulse control disorders progression in Parkinson’s disease
This study provides important insights into the potential role of the APOE gene in the development of ICDs in PD. Further studies are needed to confirm our findings and to investigate the underlying mechanisms in more detail.
Authors
- Lingqun Mao (ORCID: https://orcid.org/0009-0001-6554-8654)
- Linxi Chen (ORCID: https://orcid.org/0000-0002-2787-3018)
- Xinwei He
- Peng Liu (ORCID: https://orcid.org/0000-0002-8484-6374)
Institutions
- Taizhou Central Hospital (CN)
Publication Details
- Journal
- BMC Psychiatry
- Published
- 2024-09-27
- DOI
- https://doi.org/10.1186/s12888-024-06084-5
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- GlaxoSmithKline
- Biogen
- Teva Pharmaceutical Industries
- National Natural Science Foundation of China
- Servier
- H. Lundbeck A/S
- Taizhou University
- Genentech
- Medical Science and Technology Project of Zhejiang Province
- Natural Science Foundation of Zhejiang Province
- Science and Technology Program of Zhejiang Province